To identify new targets in KMT2A-R ALL for precision medicine approaches, we performed a kinome-wide CRISPR screen and identified multiple kinases, including DYRK1A, as required for leukemia cell survival. Here, DYRK1A is linked to acute lymphoblastic leukemia.